Table 2.
Study results, sensitivity and specificity of CT and MRI.
| Tumor Stage | CT Sensitivity % (95% CI) |
CT Specificity % (95% CI) |
MRI Sensitivity % (95% CI) |
MRI Specificity % (95% CI) |
p |
|---|---|---|---|---|---|
| T1-2 vs. T3-4 | 61.8 (50.8–71.7) | 85.7 (66.4–95.5) | 77.8 (67.5–85.6) | 60.9 (38.9–79.5) | ns |
| T1-3b vs. ≥T3c | 51.1 (36.0–66.1) | 80.8 (69.6–88.8) | 80.0 (65.0–89.9) | 91.8 (82.4–96.6) | p = 0.02 * |
| T1-3d vs. T4 | 21.4 (9.0–41.5) | 94.3 (86.8–97.9) | 46.4 (28.0–65.8) | 94.4 (86.9–97.9) | ns |
| Nodal stage ± | 65.5 (51.3–77.4) | 50.0 (37.2–62.8) | 58.2 (44.1–71.1) | 50.0 (37.2–62.8) | ns |
| EMVI ± | 35.0 (21.1–51.7) | 82.0 (71.4–89.5) | 50.0 (34.1–65.9) | 81.8 (71.0–89.4) | ns |
* Difference in sensitivity between CT and MRI.